Settlement guide

Zantac money claims: what does an actual order show?

The cited Delaware evidence order gives no personal payout grid. A withdrawal notice or study does not value your claim.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202613 sources

This may apply to you if

  • Preparation suggestions only; no cancer list, use-duration threshold or current firm acceptance rule is verified.
  • Describe the product, dates and diagnosis you want checked.
  • Ask a lawyer what evidence and court route apply to your own situation.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

Francis J. Jones, Jr. · Superior Court of the State of Delaware · Superior Court judge signing the cited order

Finding: The April order grants judgment for defendants for consolidated complaints filed on or before December 1, 2025; later-filed evidence is addressed separately.

Jones: April14,2026 Delaware Zantac order (opens in a new tab) · Apr 14, 2026 · Checked Oct 4, 2026

The evidence and its limits

Yonsei University College of Medicine, first-author affiliation · JAMA Network Open · 2023

Ranitidine Use and Incident Cancer in a Multinational Cohort

Design:
Cohort
Participants:
1,183,999 eligible people across eleven analytical databases: 909,168 new ranitidine users and 274,831 other H2-blocker users. Primary meta-analysis used four databases meeting stricter balance criteria.
Finding:
The primary and broader comparisons did not show a statistically significant overall cancer increase relative to other H2 blockers.
Main limitation
Prescription or dispensing data do not capture all actual or nonprescription use; individual impurity and dietary exposure were not measured. Follow-up may miss long-latency effects and rare or small differences. The paper reports distinct primary, broader and calibrated estimates; no pooled number is presented as one universal eleven-database result. No individual cause or universal safety finding.

Read the source: Ranitidine Use and Incident Cancer in a Multinational Cohort (opens in a new tab) · Checked Oct 4, 2026

The short answer

Has this Delaware order announced a settlement?
A settlement means an agreement resolving claims. The April 2026 order instead rules for the companies in a defined set of cases. It does not announce such an agreement. [8]
Does the order give an amount for one person?
No one has announced a personal payout grid in the April 14 Delaware order cited here. It does not tell you what you would receive. [8]
What affects any actual offer?
Ask a lawyer to examine the proof, court path and actual terms. A cancer study does not assign a payment or promise that your claim is accepted. [6]
What fees and costs could I owe?
Get fee and expense terms in writing before hiring a lawyer. A model rule is not this firm’s contract. Ask whether contact costs money. [1]

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

The cited Delaware evidence order gives no personal payout grid. A withdrawal notice or study does not value your claim. Ask for an actual agreement and written fee terms.

Has this Delaware order announced a settlement?

A settlement means an agreement resolving claims. The April 2026 order instead rules for the companies in a defined set of cases. It does not announce such an agreement.

It concerns the required general-cause evidence in consolidated complaints filed on or before December 1, 2025. A dated court decision should not be presented as an offer to every former drug user.

Does the order give an amount for one person?

No one has announced a personal payout grid in the April 14 Delaware order cited here. It does not tell you what you would receive.

A claim value cannot be inferred from a disease name or a website range. Ask for the actual agreement, award or other primary record supporting an amount and check whom it covers.

What affects any actual offer?

Ask a lawyer to examine the proof, court path and actual terms. A cancer study does not assign a payment or promise that your claim is accepted.

The 2023 comparison found no clear overall increase and had exposure and follow-up limits. That scientific result does not supply a damages table. Delaware’s evidence ruling also does not certify the value of a later-filed case.

What fees and costs could I owe?

Get fee and expense terms in writing before hiring a lawyer. A model rule is not this firm’s contract. Ask whether contact costs money.

The ABA model rule addresses percentages, expense deductions and possible costs after a loss. Ask how the signed terms treat expenses and any other deductions; do not assume a quoted gross amount is take-home money.

When would a payment arrive?

The court order sets no date when you get paid. Ask which actual agreement applies to you and what must happen first.

The federal February 2023 order is about cancer evidence and case procedure, not a payment order. A court date or study publication cannot replace the actual agreement for a claimant.

Should I rely on an online average?

Ask for the primary record behind the number and the people it covers. The April order supplies no personal grid to support a payout range.

Keep an advertisement separate from a judge’s ruling or signed offer. A defined state-court result does not calculate a national average for people with different products, claims, courts and evidence.

What happens when I ask for a money check?

Keep diagnosis, medicine and prior case papers, plus any actual offer. Ask for missing covered health copies and a personal filing-limit check.

Record access has exceptions. The January Delaware filing-time order applies to specified cases, not a universal new deadline. Asking about a payment does not file a complaint or extend your legal time limit.

Reported settlements in this case

Not a prediction
  • Zantac claim: what to ask and what to do

    2024 · Global settlement

    $2.2B

  • Zantac claim: what to ask and what to do

    2024 · Partial settlement

    $100M

Totals cover every claimant in each case, not one person's award. Each case settled on its own facts; none of these figures predicts what this case will pay.

Sources: us.gsk.com (Oct 9, 2024) · insurancejournal.com (Apr 23, 2024)

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Sources

  1. ABA Model Rule 1.5: feesABA Model Rule 1.5: fees
  2. Southern District of New York: time limitsSouthern District of New York: time limits · court
  3. 45 CFR 164.524: access to health records45 CFR 164.524: access to health records · regulator
  4. FDA: April2020 ranitidine withdrawal requestFDA: April2020 ranitidine withdrawal request · regulator
  5. FDA: reformulated ranitidine approvalFDA: reformulated ranitidine approval · regulator
  6. You: original multinational ranitidine cancer cohortYou: original multinational ranitidine cancer cohort · study
  7. Wang: original Taiwan ranitidine cohortWang: original Taiwan ranitidine cohort · study
  8. Jones: April14,2026 Delaware Zantac orderJones: April14,2026 Delaware Zantac order · court
  9. Jones: January29,2026 Delaware time-limit rulingJones: January29,2026 Delaware time-limit ruling · court
  10. GSK announced agreements with 10 plaintiff firms representing ~80,000 claimants (93% of pending US state-court Zantac cases) to pay up to $2.2 billion in aggregate, with full implementation expected by end of H1 2025; GSK admitted no liability. GSK also agreed to pay $70 million to resolve the Valisure qui tam complaint. Verified from GSK's own press statement.us.gsk.com · Oct 9, 2024
  11. Sanofi agreed to pay more than $100 million to settle ~4,000 Zantac cancer suits in state courts outside Delaware — the first major resolution in the litigation, averaging more than $25,000 per claim per Bloomberg's reporting (republished by Insurance Journal, Apr 23, 2024; deal announced earlier that month). Sanofi denied liability; 70,000+ suits then remained, mostly in Delaware.insurancejournal.com · Apr 23, 2024 · study
  12. MDL 2924 (S.D. Fla., Judge Robin L. Rosenberg) omnibus Daubert order (Doc 6120, 341 pages): ALL defendants' Daubert motions on general causation GRANTED and defendants' summary judgment motion GRANTED — plaintiffs 'fail to produce admissible primary evidence of general causation' that ranitidine causes cancer, ending the federal MDL claims. Verified from the court order itself.gsk.com · Dec 6, 2022 · court
  13. Federal court: February 14, 2023 Zantac order 81Federal court: February 14, 2023 Zantac order 81 · court

Checked against 10 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026